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Abstract
Background Poor early graft function (EGF) after living
donor kidney transplantation (LDKT) has been found to
decrease rejection-free graft survival rates. However, its
influence on long-term graft survival remains inconclusive.
Methods Data were collected on 472 adult LDKTs per-
formed between July 1996 and February 2010. Poor EGF
was defined as the occurrence of delayed or slow graft
function. Slow function was defined as serum creatinine
above 3.0 mg/dL at postoperative day 5 without dialysis.
Results The incidence of slow and delayed graft function
was 9.3 and 4.4%, respectively. Recipient overweight,
pretransplant dialysis and warm ischemia were identified as
risk factors for the occurrence of poor EGF. The rejection-
free survival was worse for poor EGF as compared to
immediate graft function with an adjusted hazard ratio
(HR) of 6.189 (95% CI 4.075–9.399; p \ 0.001). Long-
term graft survival was impaired in the poor EGF group
with an adjusted HR of 4.206 (95% CI 1.839–9.621;
p = 0.001).
Conclusions Poor EGF occurs in 13.7% of living donor
kidney allograft recipients. Both, rejection-free and long-
term graft survivals are significantly lower in patients with
poor EGF as compared to patients with immediate graft
function. These results underline the clinical relevance of
poor EGF as phenomenon after LDKT.
Keywords Acute rejection  Delayed graft function
(DGF)  Graft survival  Living donor kidney
transplantation (LDKT)  Poor early graft
function (pEGF)  Slow graft function (SGF)
Abbreviations
CIT cold ischemia time
WIT warm ischemia time
DGF delayed graft function
pEGF poor early graft function
SGF slow graft function
DDKT deceased donor kidney transplantation
LDKT living donor kidney transplantation
HLA human leukocyte antigen
Introduction
Excellent organ quality and ideal transplant conditions
contribute to immediate graft function (IGF) in a vast
majority of living donor kidney transplantations (LDKT).
However, poor early graft function (EGF) still occurs after
LDKT, although less frequently than after deceased donor
kidney transplantation (DDKT) [1]. Poor EGF includes
both delayed graft function (DGF) and slow graft function
(SGF). The latter recipients do not have the immediate
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serum creatinine decrease, but have sufficient EGF to avoid
dialysis within the first postoperative week. In previous
studies, SGF was defined as a serum creatinine greater than
3 mg/dL on postoperative day 5. The incidence of SGF was
found to be 9.5–10.7% after LDKT [2–4]. In another study,
the definition of SGF was based on the glomerular filtration
rate at postoperative day 14, and SGF occurred in 22.9%
[5]. Furthermore, a recent study showed that early graft
dysfunction after LDKT may also be defined by the
occurrence of delayed posttransplant diuresis [6].
There is clear evidence in DDKT that DGF [7–9] and
SGF [10] induce higher immunological activity and
impaired renal allograft survival. Also in LDKT, clear
evidence exist that both patients with DGF and SGF have
higher rates of acute rejection during the first postoperative
year as compared to those with IGF [2–5]. However,
existing literature is not conclusive whether or not poor
EGF impacts long-term allograft survival after LDKT
[2–5]. Two retrospective cohort studies did not find a sig-
nificant correlation between the occurrence of poor EGF
and long-term graft survival [2, 5], whereas two other
studies did [3, 4]. Therefore, we performed a retrospective




Donor and recipient characteristics, clinical data, graft and
patient survival status were retrieved from the hospital
transplantation database. Laboratory data were collected
retrospectively from the hospital electronic patient file.
Between July 1996 and February 2010, 520 patients under-
went a primary LDKT procedure. In total, 48 of 520 cases
were excluded in this study. Criteria for exclusion were: age
below 18 years and/or prior kidney transplantation.
Kidney transplantation procedure
Kidneys were procured by standard open technique using a
flank incision until October 1999. From 2001 until 2004,
donors were randomized for either a muscle splitting mini
incision open or a laparoscopic nephrectomy [11, 12].
Thereafter, laparoscopic nephrectomy was the technique of
first choice. Briefly, 4 trocars are introduced using a
pneumoperitoneum pressure of 12 mmHg. The renal artery
and vein were divided, and the kidney was extracted
through a pfannenstiel incision. Kidneys were implanted in
the recipient’s iliac fossa through an extraperitoneal
approach with vascular anastomosis to the iliac vessels.
Extravesicular ureteroneocystostomy was performed, usu-
ally with a splint. First warm ischemia time (WIT) was
defined as the period between clamping of the renal artery
and start of cold perfusion. Second WIT is the time
between ending of cold storage and recirculation in the
recipient. Cold ischemia time (CIT) is the time between the
start of cold perfusion and the beginning of the vascular
anastomosis.
Immunosuppressive protocol
All patients received intravenous methyl-prednisolone
administered in the operating room. A vast majority of
patients were treated with standard, triple immunosup-
pressive therapy including a calcineurin inhibitor (CNI),
mycophenolate mofetil (MMF) and prednisone. Monoclo-
nal antibody induction (anti-CD25 or ATG) was given to
94 patients in the setting of intervening studies (20%).
Outcome measures
DGF was defined as the need for dialysis during the first
postoperative week. SGF was defined as a serum creatinine
above 3.0 mg/dL without the need for dialysis during the
first week. All rejection episodes were biopsy-proven. In
case of clinical or laboratory evidence of graft dysfunction,
doppler ultrasound (duplex) was performed. Biopsy was
done immediately in the absence of vascular complica-
tions. During episodes of DGF, biopsies were performed at
weekly intervals. Failure of the renal allograft was defined
as return to another form of renal replacement therapy
(dialysis or re-transplantation). Our primary outcome was
death-censored renal allograft survival comparing the
group with poor EGF (DGF and SGF) to the IGF group.
Statistical analysis
Continuous variables were given as mean ± standard
deviation and were compared using analysis of variance
(ANOVA). Categorical variables were given as absolute
number of patients and percentages and were compared
using Chi-square tests. Patient and graft survival analyses
were performed using the Kaplan–Meier method, com-
pared with log-rank tests and adjusted for potential con-
founders using Cox proportional hazard regression. All
available variables were evaluated for potential con-
founding and included in the multivariate models if a sta-
tistically significant effect was demonstrated after entering
the Cox proportional hazard model as a single covariate.
We used a logistic regression model to calculate odds ratio
of risk factors for pEGF, DGF and SGF by multivariate
analysis. p values \0.05 were considered significant.
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PASW statistics version 18.0 was used for all analyses
(SPSS Inc., Chicago, IL, USA).
Results
Incidence of poor EGF
Of all recipients included in this study, 407 showed IGF
(86.2%), while 65 experienced poor EGF (13.7%) includ-
ing 44 (9.3%) patients with SGF and 21 (4.4%) with DGF.
In Table 1, baseline donor and recipient characteristics
and clinical parameters are presented. Recipients who
experienced poor EGF had a significant higher BMI as
compared to those with IGF (p = 0.011). Also subjects in
the poor EGF group had longer WITs, both WIT1
(p = 0.043) and WIT2 (p = 0.001).
Rejection-free survival
Rejection-free survival during the first ninety postoperative
days was worse for poor EGF as compared to the IGF
group (Fig. 1a; log-rank, p \ 0.001). This difference in
rejection-free survival persisted after adjusting for potential
confounders in a Cox proportional hazard model, with an
adjusted hazard ratio (HR) of 6.189 (95% CI 4.075–9.399;
Table 1 Recipient and donor characteristics and early graft function
Variables Whole group IGF (%) Poor EGF p value (poor
EGF vs. IGF)
SGF (%) DGF (%)
Number of subjects 472 407 (86.2) 44 (9.3) 21 (4.4)
Recipient age (year) 44.8 44.8 44.3 45.1 0.889
Recipient gender male 293 (62.1) 249 (61.2) 33 (75) 11 (52.4) 0.338
Recipient BMI (kg/m2) 24.0 23.9 25.1 25.0 0.011
Donor age (year) 50.1 49.9 50.5 52.9 0.351
Donor gender male 212 (44.9) 178 (43.7) 23 (52.3) 11 (52.4) 0.209
Donor BMI (kg/m2) 25.5 25.6 25.3 25.2 0.482
Pretransplant dialysis 335 (71) 281 (69) 38 (86.4) 16 (76.2) 0.026
HLA mismatches 3.2 3.2 3.4 3.7 0.172
[1 renal artery 14 11 (2.7) 1 (2.3) 2 (9.5) 0.423
WIT1 (min) 3.4 3.3 3.7 4.5 0.043
WIT2 (min) 29.8 29.0 32.2 39.6 0.001
Total CIT (min) 132 132 126 152 0.754
Right kidney 114 (24.2) 96 (23.6) 12 (27.3) 6 (28.6) 0.533
Laparoscopic 277 (58.7) 234 (57.5) 25 (56.8) 18 (85.7) 0.222
Serum creat (lmol/L)
2 weeks 157 130 292 442 \0.001
1 month 137 128 194 211 \0.001
1 year 128 124 159 143 \0.001
Disease etiology
Diabetes 22 18 3 1 0.508
Polycystic kidney 49 45 2 2 0.366
Glomerulosclerosis 8 8 0 0 0.604
Glomerulonephritis 41 34 7 0 0.458
Pyelonephritis 24 19 3 2 0.218
Initial maintenance immunosuppression
MoAb induction 94 76 10 8 0.096
Tacrolimus 346 301 28 17 0.451
Mycophenolate 433 372 40 0 0.633
Sirolimus 13 12 1 0 1.000
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p \ 0.001). The rejection-free survival of the SGF and
DGF groups both differed significantly from the IGF group
(Fig. 1b; p \ 0.001).
Death-censored graft survival
There are no significant differences in patient survival
between the poor EGF and IGF groups, nor between the
DGF, SGF and IGF groups. In Fig. 2 the death-censored
renal allograft survival is presented. Survival was worse in
the poor EGF group (Fig. 2a), and the difference was
highly significant with an adjusted HR of 4.206 (95% CI
1.839–9.621; p = 0.001). Figure 2b shows death-censored
graft survival for the SGF and DGF groups as compared to
the IGF group (log-rank p \ 0.001). When SGF was
compared to IGF, there was a significant difference with an
adjusted HR of 3.619 (95% CI 1.403–9.337; p = 0.008).
For the difference between DGF and IGF, also a signifi-
cance was found with an adjusted HR of 6.340 (95% CI
1.832–21.938; p = 0.004).
Risk factors of poor EGF
A univariate and multivariate logistic regression analysis
was performed to reveal risk factors for poor EGF. Only






Fig. 1 a Rejection-free survival during the first 90 days after LDKT in patients with IGF versus poor EGF (p \ 0.001). b rejection-free survival
in patients with IGF versus SGF (p \ 0.001) and IGF versus DGF (p \ 0.001)
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Fig. 2 a Death-censored graft survival after LDKT in patients with IGF versus poor EGF (p \ 0.001). b death-censored graft survival in patients
with IGF versus SGF (p \ 0.001) and IGF versus DGF (p \ 0.001)
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univariate analysis were included in the multivariate logistic
regression model. Recipient BMI, pretransplant dialysis,
WITs 1 and 2 were significant predictors of poor EGF.
Laparoscopic procurement and graft outcome
Figure 3 shows mean serum creatinine levels during the
first week after LDKT in recipients of allografts procured
by laparoscopic versus open techniques. Although serum
creatinine levels appeared to be slightly higher in recipients
of laparoscopically procured kidneys, differences were not
significant. Furthermore, recipients of laparoscopically
procured kidney allografts did not show significantly
higher incidences of poor EGF (Table 1). Cox regression
analysis showed that the occurrence of poor EGF impaired
long-term graft survival in recipients of kidneys procured
by both laparoscopic and open techniques, with HRs of
4.642 (95% CI 1.478–14.58; p = 0.008) and 3.795 (95%
CI 1.313–10.97; p = 0.014), respectively.
Discussion
This study shows that poor EGF following LDKT has a
large impact on long-term graft survival. Recipients with
poor EGF have a fourfold risk of graft failure as compared
to those with IGF. Recipients with SGF display almost four
times the risk of graft failure as compared to those with
immediate function; those with DGF have a sixfold risk of
graft failure. Although the phenomenon of SGF appears
less dramatic as compared to DGF, both have a substantial
deleterious impact on graft survival as compared to the IGF
group. These results are in concordance with recent studies
by Nogueira and Tyson et al. [3, 4], both describing a
retrospective cohort of kidney transplant recipients, all
receiving laparoscopically procured living donor kidneys.
The percentage of laparoscopically procured kidneys in
two other studies by Brennan and Lee et al. [2, 5] was 22
and 82%, respectively; both studies did not find a signifi-
cant association between poor EGF and graft survival. In
our cohort, 59% received a laparoscopically procured
kidney, and the occurrence of poor EGF affected long-term
survival in recipients of kidneys after open donor
nephrectomy also. This finding is in line with a recent
report on LDKT after open nephrectomy in which a cor-
relation was found between delayed posttransplant diuresis
and impaired long-term graft outcome [6]. Altogether, we
believe that our data show that the deleterious effect of
poor EGF on long-term graft survival applies for recipients
of living donor kidneys after laparoscopic and also after
open donor nephrectomy.
Multivariate analysis of covariates revealed four sig-
nificant risk factors for poor EGF, including recipient BMI,
pretransplant dialysis and warm ischemia. Recipient BMI
was also identified as a predictor of poor EGF by Nogueira
et al. [3]. These findings are in line with recent reports
showing that higher recipient BMI is associated with DGF
[13, 14]. An explanation for the association between reci-
pient BMI and poor EGF may be that the implantation of
especially right kidneys (usually with shorter renal veins)
into obese recipients is technically more challenging,
resulting in prolonged anastomosis times that may con-
tribute to the occurrence of poor EGF. Pretransplant dial-
ysis has been identified as a significant risk factor for poor
EGF. A possible explanation for this finding may be that in
patients on dialysis creatinine values prior to transplanta-
tion are higher as compared to preemptive transplanted
patients. Although creatinine levels converge between
those groups after transplantation, patients who were on
pretransplant dialysis have significantly higher serum cre-
atinine levels at day 5 (data not shown). Prolonged warm
ischemia was also revealed as a significant predictor for
poor EGF by Brennan and Nogueira et al. [2, 3]. Results
from this study provides additional evidence that a pro-
longed warm ischemia is an important determinant of poor
EGF. Interestingly, our data confirm previous findings [2,
5] indicating that the type of donor procurement (laparo-
scopic or open nephrectomy) does not affect the incidence
of poor EGF. Furthermore, we observed slightly higher
serum creatinine values after LDKT of laparoscopically
procured kidneys (Fig. 3), but these differences were not
statistically significant. Although a minimal deleterious
influence of the pneumoperitoneum on EGF could not be
ruled out, our data suggest that its impact is confined.
laparoscopic donor nephrectomy 
open donor nephrectomy
1 2 3 4 5 6 7
day after LDKT 
Fig. 3 Mean serum creatinine levels in recipients of living donor
kidney allografts procured by laparoscopic (n = 277) versus open
(n = 195) techniques
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Limitations of this study are mainly related to its ret-
rospective design. Since all consecutive kidney transplant
recipients entered the transplantation database and there
was almost no loss to follow-up, the risk of selection bias is
low. Since patients experiencing poor EGF were more
likely to receive a biopsy, some degree of observational
bias could not be ruled out. In other words, the observed
higher detection rate of (subclinical) rejection as compared
to patients with IGF may be explained by the activated
(innate) immune response in patients with early graft
dysfunction, but also by a higher likelihood to receive a
renal biopsy. Further prospective studies are required to
clarify this issue. Although we controlled for many
potential confounders in the statistical analyses, some
degree of confounding cannot be ruled out. For example,
cardiovascular comorbidity may influence EGF, but also
long-term graft and patient survival. Despite these limita-
tions, we conclude that our findings underline the need to
develop strategies to reduce the rate of poor EGF after
LDKT. These strategies may include (remote) ischemic
preconditioning to reduce the deleterious effects of renal
ischemia–reperfusion injury [15] and further shortening of
WITs.
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